Home > Boards > US Listed > Biotechs > Regeneron Pharmaceuticals (REGN)

After Recent Disappointments, Ocular Thera Pleases -- Market Talk

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
crudeoil24 Member Profile
Member Level 
Followed By 639
Posts 42,401
Boards Moderated 13
Alias Born 12/12/04
160x600 placeholder
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/7/2020 4:49:31 PM
Regeneron Announces Pricing of Public Offering of Senior Unsecured Notes PR Newswire (US) - 8/7/2020 4:05:00 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/7/2020 9:28:43 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2020 5:11:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2020 5:09:30 PM
U.S. Stock Futures Edge Higher, Gold Rallies Dow Jones News - 8/5/2020 9:32:00 AM
U.S. Stock Futures Edge Higher, Gold Rallies Dow Jones News - 8/5/2020 9:04:00 AM
U.S. Stock Futures Edge Higher, Gold Rallies Dow Jones News - 8/5/2020 8:52:00 AM
U.S. Stock Futures Edge Higher, Gold Rallies Dow Jones News - 8/5/2020 8:17:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2020 7:37:59 AM
Regeneron 2Q Profit Surges on Collaborations Dow Jones News - 8/5/2020 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2020 7:16:12 AM
Regeneron Reports Second Quarter 2020 Financial and Operating Results PR Newswire (US) - 8/5/2020 6:30:00 AM
Rowley Law PLLC is Investigating Potential Breaches of Fiduciary Duty by Officers & Directors of Regeneron Pharmaceuti... Business Wire - 8/3/2020 8:30:00 AM
Teen Scientists Win $1.8 Million at Virtual Regeneron Science Talent Search 2020 for Exemplary Research on Predicting Crop Yi... PR Newswire (US) - 7/29/2020 10:25:00 PM
Teen Scientists Win $1.8 Million at Virtual Regeneron Science Talent Search 2020 for Exemplary Research on Predicting Crop Yi... PR Newswire (US) - 7/29/2020 9:00:00 PM
BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness PR Newswire (US) - 7/29/2020 7:00:00 AM
WeissLaw LLP Investigates Regeneron Pharmaceuticals, Inc. PR Newswire (US) - 7/22/2020 8:20:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/22/2020 4:32:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/22/2020 4:31:07 PM
Vyriad Announces Initiation of Phase 2 Trial in Multiple Cancer Indications GlobeNewswire Inc. - 7/20/2020 10:00:10 AM
Kiniksa Gets FDA Orphan Designation for Rilonacept in Pericarditis Dow Jones News - 7/16/2020 8:14:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/15/2020 4:56:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/15/2020 4:52:57 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 7/15/2020 9:43:45 AM
crudeoil24 Member Level  Thursday, 10/13/16 08:41:01 AM
Re: None
Post # of 156 
After Recent Disappointments, Ocular Thera Pleases -- Market Talk
45 minutes ago - DJNF
7:49 ET - Ocular Therapeutix (OCUL) ended yesterday's trading with a $157M market cap. Regeneron (REGN) has entered a deal with the biopharma to potentially pay OCUL nearly twice that in milestone payments as part of a retinal-disease collaboration. Bigger drugmakers have made dozens of such deals with developers in recent years as to not depend just on their own pipeline but potential novel treatments created by others. In a number of cases, such agreements have ended up being the first step to a buyout. OCUL is up 23% premarket at $7.77 after having slid 8.2% this month and trading at just half of early-June levels. Then, it released more disappointing clinical data. (kevin.kingsbury@wsj.com; @kevinkingsbury)

DUKE BASKETBALL and NOTRE DAME FOOTBALL
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist